On September 10, 2024, the Canta Medical New Product Release and Technology Exchange Conference was successfully held at Liaoning Friendship Hotel. The conference attracted more than 100 industry elites and leaders to attend. At this conference, Canta Medical demonstrated its cutting-edge scientific and technological achievements in the field of oxygen production, which attracted widespread attention from both inside and outside the industry.
At the meeting, Mr. Zhu Xiaobo, founder and chairman of Canta Medical, gave a wonderful presentation on Canta Medical’s two new R&D achievements in the field of oxygen production - Canta VPSA core oxygen production technology and Canta hyperbaric oxygen chamber. He also talked about the intellectual property layout and future development direction of Canta VPSA oxygen production technology.
New scientific research products are launched
Canta has VPSA core technology and opens a new future for the oxygen production industry
In response to the many pain points of traditional oxygen concentrators, such as short service life, high energy consumption, high noise, and frequent maintenance, Canta Medical took the lead in launching a revolutionary upgrade and innovation in oxygen production technology. It used advanced technologies such as positive pressure adsorption, negative pressure desorption, and vacuum maintenance to develop the fourth-generation innovative VPSA series oxygen concentrator, which increased the oxygen production efficiency of the machine by 100% and reduced energy consumption by about 40%. At the same time, it also extended the service life and maintenance cycle of the machine by about 100%, greatly reducing the noise of the whole machine. A new solution is provided for the energy saving, efficiency improvement, noise reduction, and service life extension of oxygen concentrators.